Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 10/20 | 0.34 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.34 |
| ▸ | STING1 | Q86WV6 | 2/20 | 0.33 |
| ▸ | HINT1 | P49773 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24081953 | 0.94 | NT5E (0.35) | NT5E | |
| SCHEMBL23760804 | 0.89 | ADORA3 (0.42) | NT5E | |
| SCHEMBL24081952 | 0.84 | CA12 (0.36) | NT5ECA12CA1CA2CA9 | |
| SCHEMBL23760890 | 0.84 | CA5A (0.42) | NT5E | |
| SCHEMBL23760891 | 0.84 | CA5A (0.42) | NT5E | |
| SCHEMBL21136209 | 0.80 | CA12 (0.35) | NT5ECA12CA1CA2CA9 | |
| SCHEMBL23761021 | 0.80 | NT5E (0.31) | NT5E | |
| SCHEMBL18067110 | 0.78 | NT5E (0.40) | NT5ECA12CA1CA2CA9 | |
| SCHEMBL19644803 | 0.78 | NT5E (0.40) | NT5ECA12CA1CA2CA9 | |
| SCHEMBL23760923 | 0.76 | NT5E (0.47) | NT5E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3865136-A1 | 2'-SUBSTITUTED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR CORONA VIRUS TREATMENT | ATEA Pharmaceuticals, Inc. (US) | 2021-08-18 | — | — | EP | disclosed |